Algert Global’s AngioDynamics ANGO Stock Holding History

Algert Global’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$199K	Buy	+17,540	New	+$190K	﹤0.01%	1080
2025 Q4	–	Sell	-13,620	Closed	-$152K	–	1133
2025 Q3	$152K	Buy	+13,620	New	+$131K	﹤0.01%	1063
2024 Q1	–	Sell	-13,970	Closed	-$110K	–	1074
2023 Q4	$110K	Sell	13,970 -104,370	-88%	-$724K	﹤0.01%	1064
2023 Q3	$865K	Buy	118,340 +66,180	+127%	+$551K	0.04%	595
2023 Q2	$544K	Buy	52,160 +15,810	+43%	+$152K	0.02%	799
2023 Q1	$376K	Buy	+36,350	New	+$465K	0.02%	893
2017 Q3	–	Sell	-94,001	Closed	-$1.52M	–	301
2017 Q2	$1.52M	Sell	94,001 -50,483	-35%	-$798K	0.43%	105
2017 Q1	$2.51M	Buy	144,484 +13,381	+10%	+$224K	0.68%	26
2016 Q4	$2.21M	Buy	131,103 +89,216	+213%	+$1.49M	0.63%	33
2016 Q3	$735K	Buy	+41,887	New	+$679K	0.21%	184

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Broadfin Holdings Melville, New York $23.5M AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

WCM

Weber Capital Management San Francisco, California $100M AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAM

Bastion Asset Management Montreal, Canada $328M AUM 13.57% 1-Year Est. Return

Algert Global's ANGO Position: Q1 2026 in Review

Algert Global opened a new position in AngioDynamics (ANGO) in Q1 2026: 17,540 shares worth $199K. The stake represents ﹤0.01% of the portfolio and ranks #1080 among its holdings. This is a return to the name: Algert Global previously reported a position in ANGO as recently as Q3 2025.

Algert Global first reported a position in ANGO in Q3 2016 and has held it in 10 quarters since. The position peaked at $2.51M in Q1 2017. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

Algert Global held 17,540 shares of AngioDynamics worth $199K as of Q1 2026.
AngioDynamics was a new Algert Global position in Q1 2026.
AngioDynamics made up ﹤0.01% of Algert Global's portfolio in Q1 2026, its #1080 holding.
Algert Global first reported a position in AngioDynamics in Q3 2016 and has held it in 10 quarters since.
Algert Global's AngioDynamics position peaked at $2.51M in Q1 2017.
147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.